Research article · 15 Apr 2026
Conference abstractPublished 26 Jun 2014
Region specific cardiology perspectives on the cardiorenal syndrome - Challenges and solutions
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
C ongestive Heart Failure (CHF), a leading cause of morbidity and mortality in the Northern Territory (NT) and developed world, when confounded with concomitant renal insufficiency is associated with significant additional risk. The NT and remote Australia has a unique multiethnic demography, including a sizeable Indigenous population, spread over large geographical distances. Sixty percent live in 2 major towns serviced by 2 major public hospitals. Additional factors that can affect CHF management are prevalent in remote areas and are not well addressed within randomized controlled trials. The prevalence of renal insufficiency in CHF in the NT is significant. Accurate prospective data is lacking, however is likely greater than 40%. Co-morbid contributors and associations, in particular DM, HT, IHD, RHD, contribute further to the increased risks. Challenges continue to exist in accurately estimating the size of the problems, accurate diagnostics, disease prevention, and chronic disease management. This talk is focused on: firstly, exploring the size of the problem; secondly, exploring the available evidence from the major randomized CHF pharmaceutical trials; thirdly, a brief review of diagnostic renal injury and functional markers; and finally, exploring simple therapeutic options. The focus of these discussions has regional specific themes, however the broader themes may have universal appeal. A need to consider a wider therapeutic paradigm, from the standard guidelines is also discussed, as novel therapeutic options have been relatively slow to come by.
Subjects
Nephrology & UrologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Journal of Nephrology & Therapeutics.
Brief report · 30 Mar 2026
Renal Fibrosis: Targeting Pathways For New Therapies
Brief report · 30 Mar 2026
SGLT2 Inhibitors: A New Era for Diabetic Kidney Disease
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Nephrology & Therapeutics
- SubjectNephrology & Urology
- BylineArticles whose byline prints “Pupalan Iyngkaran”
